oncology
Philips and Illumina partner up for integrated genomics oncology solution
January 11, 2017Research and Development Illumina, Philips, oncology
Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …
Gilead makes move in oncology by snaffling Riva from Novartis
January 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology
Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
Woodley Equipment Exhibiting at Clinical Operations in Oncology Trials Europe
November 24, 2016clinical research, clinicaltrials, oncology
Woodley Equipment is exhibiting at Clinical Operations in Oncology Trials Europe, which is taking place on 29th and 30th November Steigenberger …
Cancer Research UK enters new oncology partnership
November 7, 2016Sales and Marketing Cancer Research UK, TYG Oncology, oncology
Cancer Research UK (CRUK) and its commercial arm, Cancer Research Technology (CRT), haven entered into an agreement with TYG Oncology …
Promising new study for children’s brain cancer
November 1, 2016Manufacturing and Production brain cancer, children, oncology
There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …
FDA grants $23 million to boost research on rare diseases
October 19, 2016Research and Development Cancer, FDA, clinical trials, oncology
The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …
IBM and Quest forge precision cancer treatment partnership
October 18, 2016Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
Pharmafocus: Advances in Oncology available now!
September 30, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, oncology, pharmafocus supplement
The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the …
Foundation Medicine adds new immunotherapy features to its gene profiling products
August 23, 2016Manufacturing and Production, Research and Development FoundationOne, oncology, tumour
Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …
Pfizer acquires Medivation for $14 billion
August 22, 2016Sales and Marketing Medivation, Pfizer, acquisition, oncology
Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …
GSK, Roche and Novo back $86 million immuno-oncology startup
August 17, 2016Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology
Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …
Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial
August 4, 2016Research and Development Adaptimmune, T cell, oncology, t-cell
Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …
Celgene says its Revlimid gets European approval to treat rare non-Hodgkin’s lymphoma
July 15, 2016Medical Communications, Research and Development, Sales and Marketing Celgene, European Commission, Revlimid, drug approval, drug trial, oncology
Celgene (Nasdaq: CELG) said the European Commission (EC) has approved Revlimid (lenalidomide) to treat a rare form of non-Hodgkin’s lymphoma.
Federal panel to review proposal for first human CRISPR test
June 20, 2016Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology
A US Federal safety board is set to review a proposal for the first human use of the gene editing …
Nice backs BMS’ combination immunotherapy Opdivo, Yervoy to treat skin cancer
June 17, 2016Medical Communications, Research and Development, Sales and Marketing BMS, NICE, oncology, opdivo, regulation, skin cancer
The National Institute for Health and Care Excellence (Nice) has backed a combination of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) and …
